Dyck
Pages
-
-
1973 British Journal of Psychiatry Melleril
-
For the disordered mind. Melleril Suspension offers a real prospect of prompt symptom relief. Melleril is a major tranquilliser with an impressive clinical record in acute schizophrenia. Within 24 hours of starting Melleril a tranquillising effect is seen; in 3-4 days the patient becomes calm, co-operative and sociable, and by the end of the first week the target symptoms have begun to respond. Melleril Suspension., Thioridazine, Sandoz, A pair of glasses with eyes seen in the lenses.
-
-
1973 British Journal of Psychiatry Modecate
-
From the 60's to the 70's. Pioneered by Squibb some 6 years ago, the long-acting fluphenazines have made possible improved patterns of care for the schizophrenic. A new era in the management of schizophrenia Modecate. Modecate is designed to overcome the obvious limitations of oral medication. Modecate continues to help the psychiatrist and his team to provide the schizophrenic patient with a better chance of life in the community., Fluphenazine Decanoate, Squibb, A syringe is pictured on a brown background.
-
-
1973 British Journal of Psychiatry Motival
-
In emotional disturbances Motival can produce marked and dramatic relief within the first week of treatment and often within the first 2-3 days., Fluphenazine; Nortriptyline Hydrochloride, Squibb, Multiple images of different patients, some females, some males, all with a negative or neutral expression on their face. Some of them are at work, others are looking toward the floor or off into the distance.
-
-
1973 British Journal of Psychiatry Nardil
-
This man is an island. He is a phobic patient, living alone with his fear and anxiety. Nardil, a proven MAO inhibitor, will help bring him back to the mainland of society. The evidence of Nardil's effectiveness in phobic states is increasing with usage. One patient, 26 years of age, had suffered from phobic anxiety for over ten years; a number of treatments had failed to alleviate his condition. "Phenelzine was started in doses of 15 mg t.d.s., and within two weeks there has been a complete change in his behaviour. He looked relaxed, did not complain, talked freely and was able to go to the town, which he had not been able to do for over twelve months." In 1970, the Practitioner published its first major review of psychotropic drugs for three years; Nardil was selected as the most valuable drug for combination therapy in the treatment of phobic states. "And patients with atypical depression, particularly those in whom phobic anxiety symptoms are prominent, will respond dramatically and almost specifically to the combination of an MAO inhibitor, such as phenelzine, with chlordiazepoxide or diazepam.", Phenelzine, William R Warner & Co., A black-and-white photo of a man, holding his hands together, looking towards the ground with a negative expression on his face.
-
-
1973 British Journal of Psychiatry Nardil
-
For the nameless fear Nardil. For many patients with phobic anxiety, terror has no specific cause - it's a faceless chimera. Nardil is now known to offer hope of dramatic improvement in these relatively non-specific phobias - particularly social phobias and agoraphobia. In one recent controlled study, Nardil proved successful in a majority of patients with phobic anxiety - acting, in the authors' opinion, not as a typical antidepressant, but as a special kind of anxiolytic. "…in agoraphobia and social phobias phenelzine has a definite place in treatment.", Phenelzine, William R Warner & Co., Half a face with only the left eye/eyebrow and mouth visible; the rest of the "face" is whited out. Inside the eye and mouth are brick walls.
-
-
1973 British Journal of Psychiatry Neulactil
-
n an aggressive age there is a clear place for Neulactil. 'Neulactil' seals the non-aggression pact. Aggression, in the "naughty" child, the antisocial adolescent, the irritable geriatric, the psychopathic delinquent - whenever, in fact, it manifests itself as a symptoms of disturbed behaviour - is a clear indication for treatment with 'Neulactil.' Clinical experience continues to confirm the unique action of 'Neulactil' as a powerful inhibitor of aggression and impulsiveness and as a regulator of mood and reducer of anxiety in patients of all ages. It is shown to be of great value in lessening excitement and hostility, improving contact and sociability, promoting composure and harmony. 'Neulactil,' moreover, achieves and maintains these results at dosage levels which rarely cause unpleasant or unwanted side effects., Pericyazine, May & Baker, A hand holding a broken glass bottle.
-
-
1973 British Journal of Psychiatry Nydrane
-
Be specific. Choose Nydrane. Nydrane (beclamide) has specific action in the treatment of all types of character and behaviour disorders in adults and children, both epileptic and non-epileptic, particularly is instability is marked and aggressiveness a feature. Nydrane is non-toxic, making routine blood counts unnecessary, and non-sedative, so it is specially useful for children of school age. As adjuvant therapy in grand mal and psychomotor epilepsy Nydrane frequently permits reduced levels of anti-convulsants to be used. Nydrane is also free from side effects commonly associated with anticonvulsant drugs, including gum hypertrophy and somnolence. Nydrane does so much more then merely mask the symptoms in behaviour disorders., Beclamide, Rona Laboratories, A black-and-white sketch of a female's face; the face is positioned to seem as if the head is pointed upwards; the eyes are closed.
-
-
1973 British Journal of Psychiatry Orap
-
Her lonely world is often peopled by strange and frightening happenings.Delusions, hallucinations, withdrawal, the bizarre symptoms that haunt the schizophrenic are now commonly associated with an excess of cerebral dopamine. Selective blockade of this neurotransmitter by Orap (pimozide) offers the psychiatrist a new dimension in the treatment of schizophrenia. Now the inactive and apathetic schizophrenic can be treated with only a remote risk of noradrenaline blockade and hence undesired sedation and stupor can be avoided. With little or no Parkinsonian side effect liability Orap is well accepted by patients. They become amenable and co-operative during rehabilitation and are able to undertake tasks requiring mental alertness. Once-a-day Orap. "especially indicated for schizophrenics who are inactive and apathetic and for these patients it appears to be superior to previously available neuroleptics.", Pimozide, Janssen Pharmaceuticals, A black-and-white photo of a women sitting on a park swing, with the ground around her wet as if it is raining.
-
-
1973 British Journal of Psychiatry Ospolot
-
Do your patients join in? Alive and alert - their epilepsy well controlled. Ospolot - the first line treatment in epilepsy. Ospolot - broad spectrum anticonvulsant effective in: grand mal, focal attacks, temporal lobe apilepsy, myoclonic jerks, hyperkinetic syndrome. Ospolot - effective when used alone: high margin of safety, non-barbiturate, well-tolerated., Sulthiame, Bayer, A group of six boys playing basketball; some of them are running towards the net, others are jumping at the net.
-
-
1973 British Journal of Psychiatry Ospolot
-
Ospolot improves behaviour. Now he joins in. For patients with behaviour problems such as: hyperactivity, aggressiveness, destructiveness, antisocial activity. Ospolot improves behaviour whether the cause is epilepsy, E.E.G. dysrhythmias, hyperkinetic syndrome, mental subnormality, psychotic activity. Suitable for in-patents and out-patients. In-patients are made more managebale and nursing is made easier. Out-patients achieve greater employment potential, greater concentration, less family stress and better social adjustment., Sulthiame, Bayer, A group of four children standing at a table and putting a puzzle together.
-
-
1973 British Journal of Psychiatry Praxilene
-
In cerebral ischaemia Praxilene puts life into living. The cerebral activator Praxilene. 'Mental deterioration of an older person will throw an unbearable strain on the family and is extremely difficult to improve.' Praxilene can re-orientate elderly confused patients enabling them to live more fully, to take greater part in daily activities, and most importantly, to ease the burden on the family or nusing staff, through the increased awareness and co-operation of the patients in their care., Naftidrofuryl, Lipha, Multiple different images of different older individuals taking part in daily activities such as cleaning, ironing, drinking, etc.
-
-
1973 British Journal of Psychiatry Priadel
-
The first controlled release preparation of lithium carbonate in the world. Priadel reduces the frequency and duration of recurrent depressive and manic-depressive episodes. Clinical trial results: Priadel prevented relapse in 86% of patients, Priadel eliminated the need for ECT, Priadel reduced the time spent in hospital from 26.9 weeks to 3.5 weeks. The majority of depressive and manic-depressive patients experience an increase in frequency and intensity of relapse with advancing age. After three or more episodes patients treated by conventional methods can expect to spend nearly half their lives incapacitated by their illness. The risk of suicide also increases and more than 15 per cent will kill themselves. Retrospective studies suggested that as many as 20 percent of 100 known suicides might have been prevented by the prophylactic use of lithium., Lithium Carbonate, Delandale Laboratories, A series of blue and grey rectangular prisms placed in a random order in series; they start larger from the left and become smaller as they go towards the right of the page. Also an enlarged image of a Priadel tablet.
Pages
